(VIANEWS) – NASDAQ Composite opens in less than two hours and Horizon Therapeutics‘s pre-market value is already 9.18% up.
The last session, NASDAQ Composite ended with Horizon Therapeutics (HZNP) dropping 0.02% to $99.76. NASDAQ Composite rose 0.55% to $14,761.30, after two sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session.
Today’s last reported volume for Horizon Therapeutics is 1918852, 23.7% above its average volume of 1551188.
Horizon Therapeutics’s last close was $100.02, 4.62% under its 52-week high of $104.86.
Horizon Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 3.8%, now sitting on 2.19B for the twelve trailing months.
Horizon Therapeutics’s last day, last week, and last month’s current volatility was 2.59%, 1.40%, and 1.50%, respectively.
Horizon Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.17% (day), 2.99% (last week), and 2.80% (last month), respectively.
More news about Horizon Therapeutics (HZNP).